Measurement of cetuximab and panitumumab-unbound serum EGFR extracellular domain using an assay based on slow off-rate modified aptamer (SOMAmer) reagents.

Park, Noh Jin

Measurement of cetuximab and panitumumab-unbound serum EGFR extracellular domain using an assay based on slow off-rate modified aptamer (SOMAmer) reagents. [electronic resource] - PloS one 2013 - e71703 p. digital

Publication Type: Journal Article

1932-6203

10.1371/journal.pone.0071703 doi


Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Agents--administration & dosage
Aptamers, Nucleotide--genetics
Binding Sites
Binding, Competitive
Biomarkers--blood
Cetuximab
Clinical Laboratory Techniques--methods
Enzyme-Linked Immunosorbent Assay
ErbB Receptors--antagonists & inhibitors
Humans
Panitumumab
Polymerase Chain Reaction
Receptor, ErbB-2--antagonists & inhibitors
Receptor, ErbB-3--antagonists & inhibitors
Receptor, ErbB-4
Reproducibility of Results